IRIS Institutional Research Information System - OPENBS Open Archive UniBS

COSTA, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 790
EU - Europa 218
AS - Asia 112
Continente sconosciuto - Info sul continente non disponibili 3
Totale 1.123
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 790
CN - Cina 85
UA - Ucraina 76
DE - Germania 44
IT - Italia 33
FI - Finlandia 23
HK - Hong Kong 21
IE - Irlanda 12
FR - Francia 11
GB - Regno Unito 8
GR - Grecia 6
EU - Europa 3
IN - India 3
TR - Turchia 2
AT - Austria 1
ES - Italia 1
IS - Islanda 1
KW - Kuwait 1
SE - Svezia 1
SI - Slovenia 1
Totale 1.123
Salva come PNG Salva come JPEG
Città #
Fairfield 105
Ashburn 90
Chandler 77
Woodbridge 73
Houston 72
Jacksonville 51
Cambridge 37
Seattle 37
Wilmington 37
Dearborn 25
New York 25
Princeton 24
Ann Arbor 20
Hong Kong 20
Beijing 18
Helsinki 17
Dublin 12
Brescia 9
Nanchang 9
Nanjing 9
Changsha 8
Shanghai 7
Athens 6
Ceto 6
Des Moines 6
San Diego 6
Washington 6
Falls Church 4
Kunming 4
Shenyang 4
Haikou 3
Hangzhou 3
Hebei 3
Jinan 3
London 3
Tianjin 3
Boardman 2
Guangzhou 2
Gunzenhausen 2
Kocaeli 2
Lancaster 2
Milan 2
Ningbo 2
Redwood City 2
San Francisco 2
Berlin 1
Böblingen 1
Cambados 1
Chengdu 1
Chicago 1
Hefei 1
Hounslow 1
Jiaxing 1
Kuwait City 1
Ljubljana 1
Newark 1
Orange 1
Rende 1
Reykjavik 1
Taizhou 1
Treviglio 1
Verona 1
Vienna 1
Zhengzhou 1
Totale 879
Salva come PNG Salva come JPEG
Nome #
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 137
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 135
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage I and II disease 129
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 124
Clinical outcomes and toxicity after exclusive versus postoperative radiotherapy in supraglottic cancer: new solutions for old problems? The case of stage III and IV disease 123
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 107
Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy 106
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 82
The linguistic validation process of the Vanderbilt Head and Neck Symptom Survey - Italian Version (VHNSS-IT) 63
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 63
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 62
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 32
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 8
Totale 1.171
Salva come PNG Salva come JPEG
Categoria #
all - tutte 4.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201968 0 0 0 0 0 0 0 0 0 0 37 31
2019/2020291 34 15 8 26 16 42 35 29 19 42 10 15
2020/2021213 6 18 14 20 5 25 2 25 19 40 19 20
2021/2022107 6 4 5 7 4 7 2 10 5 16 6 35
2022/2023170 13 12 4 17 21 32 0 18 37 1 8 7
2023/2024141 8 3 25 11 6 41 14 7 20 4 2 0
Totale 1.171